Managers

Venture investing softens but maintains strong pace in Q3

IPO Profiles: Roku leads pack of seven VC-backed IPOs in September

Carrick Capital targets $400 mln for third venture fund

Carrick Capital Partners is seeking to raise $400 million for its third venture fund, according to an SEC filing. In February 2015, the San Francisco-based firm closed its second fund at $275 million.

Israeli investor Stageone builds bridge to Silicon Valley software startups

Can Peter Thiel pull a rabbit from his hat with Palantir?

MDC Capital raises $200 mln venture fund

MDC Capital has raised a $200 million venture capital fund, according to a filing with the SEC.

VCs on the Move, recap

On the Bleeding Edge: Rebecca Lynn's latest fintech deal, and PC West preview

Frontier Venture Capital raises $2.1 mln toward $25 mln fund

Frontier Venture Capital has raised $2.1 million toward a $25 million early stage venture-capital fund, according to a filing with the SEC.

Macrolide Pharmaceuticals names two to board

Watertown, Massachusetts-based Macrolide Pharmaceuticals, a developer of antibiotics for for drug-resistant, hospital-acquired infections, has appointed Christopher Viehbacher and Dr. Markus Goebel to its board of directors. Viehbacher is a managing partner at Gurnet Point Capital and chairman of Boston Pharmaceuticals while Goebel is a managing director at Novartis Venture Fund.